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ABSTRACT: The endoplasmic reticulum chaperone gp96 is
required for the cell surface expression of a narrow range of
proteins, including toll-like receptors (TLRs) and integrins. To
identify a more comprehensive repertoire of proteins whose cell
surface expression is dependent on gp96, we developed plasma
membrane profiling (PMP), a technique that combines SILAC
labeling with selective cell surface aminooxy-biotinylation. This
approach allowed us to compare the relative abundance of plasma
membrane (PM) proteins on gp96-deficient versus gp96-
reconstituted murine pre-B cells. Analysis of unfractionated
tryptic peptides initially identified 113 PM proteins, which
extended to 706 PM proteins using peptide prefractionation.
We confirmed a requirement for gp96 in the cell surface
expression of certain TLRs and integrins and found a marked
decrease in cell surface expression of four members of the extended LDL receptor family (LDLR, LRP6, Sorl1 and LRP8) in the
absence of gp96. Other novel gp96 client proteins included CD180/Ly86, important in the B-cell response to lipopolysaccharide.
We highlight common structural motifs in these client proteins that may be recognized by gp96, including the beta-propeller and
leucine-rich repeat. This study therefore identifies the extended LDL receptor family as an important new family of proteins
whose cell surface expression is regulated by gp96.
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■ INTRODUCTION
Gp96 (also known as gpr94 or HSP90b1) is a ubiquitously
expressed chaperone and the only ER resident member of the
HSP90 family.
1 Gp96 has several biological functions, of which
the best recognized is its role in the folding and assembly of
membrane proteins of the secretory pathway. In the absence of
gp96 these proteins are targeted for ER-associated degradation
(ERAD).
1 However, the chaperone activity of gp96 is selective,
with targets including integrins, toll-like receptors (TLRs),
insulin-like growth factors (IGFs), thyroglobulin and the
platelet glycoprotein Ib-IX-V complex.
2−8 The selectivity of
gp96 as a chaperone is illustrated by the case of the integrin
family.
3 While many integrins require chaperoning by gp96,
some α- and β-integrins are gp96 independent.
2,9 The first
reported gp96 clients came from the immunoglobulin family.
10
However, serum immunoglobulins are normal in mice with a B-
cell selective gp96-depletion, suggesting that folding of
immunoglobulins is gp96-independent.
11 Other than the
presence of disulfide bonds, no common structural feature of
gp96 clients has emerged.
12
To gain a more complete understanding of cell surface
receptors whose expression is dependent on gp96, we
developed an unbiased proteomics approach for the selective
enrichment of plasma membrane proteins. Selective oxidation
and aminooxy-biotinylation of sialylated PM glycoproteins,
followed by off-line high pH reversed-phase HPLC (HpRP-
HPLC) fractionation allowed the mass spectrometry identi-
fication of up to 700 PM proteins, as defined by gene ontology
(GO) terms. Using this technique, we performed a SILAC-
based differential analysis of plasma membrane proteins whose
expression is dependent upon gp96. A comparison of gp96-
knockout and gp96-reconstituted murine pre-B cells
3,13 found
that the cell surface expression of 29 proteins was decreased
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gp96 dependence of integrins α4, αV, αL, β2 and toll-like
receptors TLR6 and TLR4, and the lack of dependence of the
α6 and β1 integrins.
2−4,9,11 We now report that gp96 is
required for cell surface expression of four members of the
LDLR family: (i) the founding member LDLR, which plays a
central role in regulating the concentration of plasma LDL and
when absent leads to familial hypercholesterolaemia,
14 (ii) the
Wnt signaling protein lipoprotein receptor-related protein-6
(LRP6) which participates with Frizzled proteins as coreceptors
in Wnt signaling,
15 (iii) the sortilin related receptor Sorl1
implicated in the pathogenesis of Alzheimer’s disease,
16 and
(iv) LRP8 (apolipoprotein E receptor 2) required for neural
development through Reelin signaling.
17 None of the
remaining six members of the LDLR family were detected by
mass spectrometry. Our data suggest that LDL receptor family
members are dependent on gp96 for optimal cell surface
expression.
■ MATERIALS AND METHODS
Cells and Cell Culture
All cell lines were derived from the murine pre-B-cell line 70Z/
3, as described previously. The NF-κB reporter cell line GTPT3
was engineered to express three NF-κB-dependent markers for
previous studies of IKKγ mutants.
18 GTPT3 cells were
mutagenised with ICR191 (Sigma), and individual clones
derived. The resulting M36 clone has two frameshift mutations
in the ORF of gp96, resulting in production of a truncated
nonfunctional protein.
13 M36/gp96+ cells were derived by
stable transduction of M36 cells with gp96.
13 M36 and M36/
gp96+ cells were used for the majority of the analysis in our
study. The E4.126 clone was independently derived from 70Z/
3 cells by ICR191 mutagenesis, and also carries two
frameshifting mutations in gp96.
3,13 All cells were grown in
SILAC RPMI 1640 medium (Thermo Pierce, Cramlington,
U.K.) supplemented with 10% dialyzed fetal calf serum (FCS)
(JRH Biosciences, Lenexa, KS), Penicillin at 100 units/mL,
Streptomycin at 0.1 mg/mL (Sigma, Dorset, U.K.) and 50 μM
Mercaptoethanol (Sigma). Media was supplemented with
either light (Arg 0, Lys 0, Sigma) or heavy (Arg 10, Lys 8,
Cambridge Isotope Laboratories, Andover, MA) amino acids at
50 mg/L and L-proline at 280 mg/L.
19
Preparation of PM Proteins Using Aminooxy-biotin
We have optimized our procedure
20 for enrichment of PM
proteins for proteomic analysis, as described below (Figure 1).
M36 cells were grown in light media, and M36/gp96+ cells in
heavy media for seven divisions. 1.2 × 108 of each cell type
were pooled in a 1:1 ratio and washed twice in ice-cold PBS pH
7.4 (Sigma). All of the following steps were performed on ice.
An oxidation/biotinylation mix
21 comprising 1 mM sodium
meta-periodate, 100 mM aminooxy-biotin (Biotium Inc.,
Hayward, CA) and 10 mM aniline (Sigma) in ice-cold PBS
pH 6.7 was vortexed with aniline added immediately prior to
vortexing. Surface sialic acid residues were oxidized then
biotinylated by resuspending cells in 6 mL mix (1 mL per 4 ×
107 cells) with rocking in the dark. The oxidation reaction was
quenched by glycerol to 1 mM final concentration. Cells were
washed once in PBS pH 7.4/5% (v/v) FCS, then once in PBS
pH 7.4. PBS contained 1 mM CaCl2 and 0.5 mM MgCl2.
Biotinylated cells were centrifuged at 400× g at 4 °C for 5 min,
and the resulting cell pellet was resuspended and incubated at 4
°C for 30 min in lysis buffer (1% Triton X-100 (high purity,
Thermo), 150 mM NaCl, 1× protease inhibitor (complete,
without EDTA (Roche)), 5 mM iodoacetamide (Sigma), 0.1
mg/mL PMSF and 10 mM Tris-HCl pH 7.6). Nuclei were
removed by centrifugation at 4 °C, initially at 2800× g then
twice at 16000× g. Biotinylated proteins were enriched by
incubating for 2 h at 4 °C with 144 μL high affinity streptavidin
agarose beads (6 μL beads per 107 input cells, Pierce).
Extensive washing was performed using a vacuum manifold and
Snap Cap spin columns (Pierce). All washes or incubations in
the following description were with 600 μLb u f f e r ;a l l
centrifugation steps were performed at 1000× g for 1 min.
Beads were initially washed 20 × with lysis buffer, 20× with
PBS/0.5% (w/v) SDS and incubated for 20 min at RT with
PBS/0.5% (w/v) SDS/100 mM DTT, then centrifuged.
Further washing was performed 20× with UC buffer (6 M
urea, 100 mM Tris-HCl pH 8.5), followed by alkylation for 20
min at RT with UC buffer containing 50 mM iodoacetamide.
Beads were washed (20× per step with centrifugation after each
step), using UC buffer, 5 M NaCl, 100 mM Na2CO3, PBS then
water, resuspended in 400 μL5 0m MN H 4HCO3 containing 5
μg modified sequencing grade trypsin (Promega), then
transferered to a protein LoBind tube (Eppendorf), where
biotinylated glycoproteins were digested on-beads overnight.
Beads were transferred to a Snap Cap spin column and tryptic
peptides collected by centrifugation at 1000× g for 1 min.
Beads were rinsed once with 50 mM NH4HCO3, and tryptic
fractions pooled. Ten percent of the resultant digest was
d e s a l t e da n dc o n c e n t r a t e db yS t a g e T i p
22 for immediate
analysis. The remaining tryptic peptide sample was fractionated
by HpRP-HPLC (see below). To elute glycopeptides, beads
were washed with PBS, then water, then G7 buffer (New
Figure 1. Plasma membrane profiling workflow. Heavy and light
labeled cells are mixed early in the procedure and sialylated
glycoproteins oxidized and biotinylated. The enriched glycoproteins
are digested and bound N-linked glycopeptides are released using
PNGase F. Eluates are prepared for LC−MS/MS.
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in 400 μL G7 buffer containing 30000 units of glycerol free
PNGase (New England Biolabs). Glycopeptides were collected
by centrifugation at 1000× g for 1 min, beads were washed
once with G7 buffer, and eluates pooled and concentrated on a
StageTip.
22
Biotinylation was confirmed by staining aliquots of cells prior
to and after biotinylation with streptavidin-allophycocyanin
(eBioscience, San Diego, CA). The incorporation of heavy label
was checked by analysis of a lysate of 3 × 106 heavy labeled
cells, generated using SDS/DTT/Tris (SDT) buffer and Filter
Aided Sample Processing (FASP).
23 Incorporation was >98%
for both arginine and lysine-containing peptides.
High pH reverse-phase high pressure liquid
chromatography (HpRP-HPCL) fractionation and mass
spectrometric analysis
A total of 100 μg of tryptic peptide was subjected to HpRP-
HPLC fractionation using a Dionex Ultimate 3000 powered by
an ICS-3000 SP pump with an Agilent ZORBAX Extend-C18
column (4.6 mm × 250 mm, 5 μm particle size). Mobile phases
(H20, 0.1% NH4OH or MeCN, 0.1% NH4OH) were adjusted
to pH 10.5 with the addition of formic acid and peptides were
resolved using a linear 40 min 0.1−40% MeCN gradient over
40 min at a 400 μL/min flow rate and a column temperature of
15 °C. Eluting peptides were collected in 15 s fractions.
Fractions were dried down using an Eppendorf Concentrator
and resuspended in 8 μL MS solvent (3% MeCN, 0.1% TFA).
Fractions 25 to 152 inclusive were analyzed and in each case 3
μL was injected and subjected to LC−MS/MS using a
NanoAcquity uPLC (Waters, MA) coupled to an LTQ-
OrbiTrap XL (Thermo, FL, UA). Peptides were eluted using
a gradient rising from 7 to 25% MeCN by 30 min, 40% MeCN
by 39 min and 85% MeCN by 42 min. MS data was acquired
between 400 and 2000 m/z at 60000 fwhm with lockmass
enabled (445.120025 m/z). CID spectra were acquired in the
LTQ with MSMS switching operating in a top 6 DDA fashion
triggered at 500 counts. Unfractionated peptides were eluted
using a gradient rising from 3 to 25% MeCN by 90 min, 40%
MeCN by 110 min and 85% MeCN by 115 min. Spectra were
acquired using the same MS parameters.
Database Searching and Data Processing
Raw MS files were processed in parallel using MaxQuant
versions 1.0.13.13 and 1.1.1.14.
24,25 Data were searched against
the International Protein Index mouse database release 3.68
using MASCOT Daemon 2.3.2 and Andromeda version
1.1.1.14.
25 Fragment ion tolerance was set to 0.5 Da with a
maximum of 2 missed tryptic cleavage sites. Carbamidomethyl
cysteine was defined as a fixed modification, oxidized
methionine, N-terminal acetylation and deamidation (NQ)
were selected as variable modifications. Reversed decoy
databases were used and the false discovery rate for both
peptides and proteins were set at 0.01. Protein quantitation
utilized razor and unique peptides and required a minimum of
2 ratio counts and normalized protein ratios reported. Peptide
requantify was enabled in all analyses apart from where
indicated. Significance A values were calculated and Gene
Ontology Cellular Compartment (GOCC) terms added using
Perseus version 1.1.1.13 (downloaded from http://maxquant.
org).
To assess the number of PM proteins identified, we summed
the proteins with GOCC terms plasma membrane (PM), cell
surface but not PM (CS) and extracellular but not PM/CS
(XC). We previously identified a subset of proteins annotated
by GO as integral to the membrane, but with no subcellular
assignment and a short GOCC (ShG) term (a 4-part term
containing the terms “integral to membrane”, “intrinsic to
membrane”, “membrane part”, “cell part” or a 5-part term
containing “membrane” in addition to these terms).
20 Where a
majority of proteins identified from a given sample are
annotated PM/CS/XC, it is likely that a substantial proportion
of the proteins with a short GOCC term are also integral PM
proteinsincluding these proteins provides a useful upper
estimate of the number of identified PM proteins.
Structural Annotation and Protein−Protein Interactions
We used the method of Adachi et al.
26 to determine statistically
enriched protein domains in our data set. Briefly, Interpro
(release 34.0) was used to annotate protein structural domains,
and Cytoscape
27 plugin BiNGO
28 was used for domain
enrichment analysis. The test data set was the InterPro
annotations of all proteins we identified by ≥2 peptides and
found downregulated >3 fold in the absence of gp96. The
reference set was the InterPro annotations of all proteins we
identified by ≥2 peptides. The InterPro ontology was derived
from the interpro.xml file, InterPro release 34.0 (ftp://
ftp.ebi.ac.uk/pub/databases/interpro/). The enrichment anal-
ysis was performed using a Hypergeometric test, and we
selected all InterPro domains that were significant with p <
0.001 after correcting for multiple term testing by Benjamini
and Hochberg false discovery rate. Fold enrichment was
calculated by comparing the test set against the reference set.
Cytoscape version 2.8.2 (www.cytoscape.org) was used with
the Mimi plugin
29 to determine the known interactions of
proteins down- or up-regulated >3 fold in the absence of gp96.
Flow Cytometry
All of the following steps were performed on ice to prevent
receptor internalization. Cells were washed in ice-cold PBS pH
7.4 containing 1 mM CaCl2 and 0.5 mM MgCl2 (Sigma),
incubated for 15 min with 10 mg/mL Fc block (Vivaglobulin,
CSL Behring UK Ltd.) and stained (30 min, 4 °C) using the
following antimouse monoclonal antibodies: anti-CD44 FITC,
anti-CD18 PE, anti-H2Kb PE (Caltag Laboratories, Burlin-
game, CA) and unconjugated anti-LDLR (R and D systems,
Abingdon, U.K.). Cells were washed in PBS. Cells that had
been stained with the unconjugated anti-LDLR primary
antibody were stained (30 min, 4 °C) with antirat Cy5
(Invitrogen, Carlsbad, CA) then washed with PBS. Cells were
fixed in 1% paraformaldehyde and analyzed on a FACS Calibur
using Cellquest (BD Pharmingen) and FCSPress v1.3 (www.
fcspress.com).
■ RESULTS
Enrichment of Plasma Membrane Proteins by PMP
To identify proteins whose cell surface expression was
dependent on gp96 we further developed and improved our
plasma membrane enrichment technique, termed “plasma
membrane profiling” (Figure 1).
20 Aminooxy-biotinylated PM
proteins were prepared from M36 cells (light media) and M36/
gp96+ cells (heavy media), as described above. After capture on
streptavidin beads, proteins were digested with trypsin. Ten
percent of this tryptic peptide sample was desalted and
concentrated to confirm enrichment of PM proteins. We
identified 135 proteins, of which 89 were annotated “plasma
membrane” (PM). An additional 2 proteins were annotated
Journal of Proteome Research Communication
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total of 94 PM/CS/XC proteins, representing 70% of all
identified proteins with a GOCC annotation (Table 1).
Including the 19 proteins with a “short GO” (ShG) annotation
(described above) gave a useful upper estimate of the number
of identified PM proteins, 113 PM/CS/XC/ShG proteins
(84%). A total of 7 proteins were annotated “nucleus”,4o f
which were additionally annotated PM. The 3 nuclear proteins
not annotated PM are likely to represent contaminants (Table
1).
HPLC Fractionation of Tryptic Peptides Results in a
Substantial Increase in Identified Plasma Membrane
Proteins
As a significant number of PM proteins were identified at high
purity from the unfractionated tryptic peptide sample, we
performed HpRP-HPLC fractionation on the remaining 90% of
sample. One-hundred twenty-eight fractions were analyzed
(Figure S1, Supporting Information), and this data processed in
parallel with the PNGase fraction using MaxQuant version
1.0.13.13 (referred to as “Mascot”) and MaxQuant version
1.1.1.14 (referred to as “Andromeda”). Fractionation substan-
tially increased the total and PM protein identifications
combining the Mascot and Andromeda data, a total of 563
proteins annotated PM/CS/XC and 706 proteins annotated
PM/CS/XC/ShG were identified (Table 1, Table S1,
Supporting Information). Four-hundred fifty proteins anno-
tated PM/CS/XC and 565 proteins annotated PM/CS/XC/
ShG were quantified, out of a total of 1271 quantified proteins.
Forty-six of the 1271 proteins were downregulated >3 fold
(Table S2, Supporting Information), 29 of which were
identified by ≥2 peptides (Figure 2 and Table 2). Of these
29 proteins, 24 were annotated PM/CS/XC and 26 PM/CS/
XC/ShG (93%).
Plasma Membrane Profiling Confirms the Critical Role of
gp96 in Cell Surface Expression of Integrins and TLRs
Our data was validated by confirming the dependence on gp96
for cell surface expression of integrins α4, αV, αL, and β2,
2,3,9,11
and gp96 independence of integrins β1, α6 and α52 (Table 2
and Table S1, Supporting Information). Furthermore, flow
cytometric analysis of integrin β2 (CD18) demonstrated
decreased cell surface expression to the level of the unstained
control in two independently derived gp96-deficient cell lines
(Figure 3). We also showed that integrin α9 is gp96 dependent
(Table 2). The normal cell surface expression of integrin α1
and decreased expression of integrin β3 in gp96-deficient cells
contrasts with a previous report.
2
Two TLRs were identified. Surface localization of TLR6 was
dependent on gp96 (Table 2), as reported.
3,4,30 TLR4 was
identified by two peptides (Table S1, Supporting Information)
however no protein ratio was reported by either Mascot or
Andromeda. One of the two peptides was quantified by both
algorithms, with fold down-regulation ratios of 34.2 (Mascot)
and 14.1 (Andromeda), suggesting that surface expression of
TLR4 is dependent on gp96, as reported.
3,4
Several proteins were not dependent on gp96 for their
surface expression, including CD44, ICAM1, CXCR4, IL7R as
well as MHC class I allotypes
3,11 and this could be confirmed
by flow cytometry for CD44 and H2-Kb (Figure 3).
Finally, gp96 (Endoplasmin) was detected at the PM in
M36/gp96+ cells and showed decreased plasma membrane
expression (3.8−5.3 fold) in M36 cells (Table 2). This
corresponds to Western blotting analysis of gp96 from M36
lysates which showed a truncated protein at low abundance.
13
The two frameshifting mutations in the ORF of gp96 in M36
cells explain the loss of wild-type protein.
13
Downregulation of LDLR Family Members in gp96
Deficient Cells
Most notable of the novel proteins whose cell surface
expression is decreased in the absence of gp96 were 4 proteins
of the extended LDLR family: the LDLR itself (25.2−35.0
Table 1. Proteins Enriched using PMP were Identified by
LC−MS/MS and their Subcellular Location Inferred from
GOCC Terms
a
unfractionated
all
fractions
Mascot
all fractions
Andromeda
all
fractions
combined
Total proteins
identified
135 1709 1551 1826
Total proteins
quantified
93 1181 1137 1271
Annotations
Membrane 127 1352 1241 1433
Plasma membrane or
Cell surface (PM/
CS)
91 481 452 509
Extracellular but not
PM/CS (XC)
34 8 3 9 5 4
Short GO description
(ShG)
19 141 129 143
Nuclear but not PM/
CS/XC/ShG
3 352 318 377
Total PM/CS/XC 94 529 491 563
Total PM/CS/XC/
ShG
113 670 620 706
% PM/CS/XC of all
identified +
annotated proteins
70% 34% 35% 35%
% PM/CS/XC/ShG
of all identified
+annotated proteins
84% 44% 44% 43%
aNumbers of proteins are shown with the indicated annotations. The
percent PM/CS/XC is calculated as (PM/CS/XC annotations/(total
protein identifications − proteins without GOCC annotation)).
Figure 2. Scatterplot of all proteins identified by ≥2 peptides. Fold
change (x-axis) is shown as log2, and summed ion intensity (y-axis) is
shown as log10. Significance A values were calculated using Perseus
version 1.1.1.13.
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LRP8 (apolipoprotein E receptor 2) (5.4 fold). The other 6
members of the LDLR family (VLDLR, MEGF7, LRP1,
LRP1B, LRP2, LRP5) were not detected. This likely reflects
either low expression levels in pre-B cells, or solubility
problems since these proteins are large, ranging from 211 to
522 kDa, and may therefore not be efficiently enriched by our
PMP approach. The absolute dependence of cell surface LDLR
expression on gp96 was readily confirmed by flow cytometry in
both gp96 deficient cells (M36 and E4.126) (Figure 3). No
other antibodies suitable for flow cytometry were available for
other mouse protein family members. Given the structural
similarities of other members of the LDLR family to LDLR and
ApoER2, it seems likely that these six proteins are also gp96-
dependent, though confirmation is required given the selectivity
of gp96 for certain α-integrins.
All members of the LDLR family and more distantly related
receptors are characterized by the presence of at least one
YWTD-motif containing beta-propeller domain, with flanking
EGF-like cysteine-rich repeats.
12 Both beta-propellers and EGF
repeats have been identified as structural motifs present in
other known gp96 clients. All α-integrins contain a single
seven-bladed beta-propeller, and β-integrins contain four
cysteine-rich EGF repeats
31 Among the other proteins
dependent on gp96 for cell surface expression, attractin
contains a beta-propeller (of the Kelch-repeat type rather
than WD-repeat type); Laminin alpha 5, attractin, N-glycan
processing alpha-mannosidase IIx and EGF-containing fibulin-
like extracellular matrix protein 1 contain EGF-like domains
(Table 2).
To determine which protein structures were over repre-
sented within the downregulated proteins as compared to all
proteins identified by ≥2 peptides, we used the method of
Adachi et al.
26 Significantly enriched (p < 0.001) protein
domains or repeats were part of one of three structures: the
beta-propeller, the leucine-rich repeat, or α integrin (Figure 4).
All α-integrins and all members of the extended LDLR family
contain β-propeller motifs, suggesting that the beta-propeller
Figure 3. Flow cytometry confirms that LDLR is gp96 dependent. (a) M36 and M36/gp96+ cells or (b) the independent gp96 knockout E4.126 and
control GTPT3 cells were stained with monoclonal antibodies against the indicated cell surface targets. At least three replicate stains were performed
for each cell surface target, confirming the above observations (data not shown).
Figure 4. Fold enrichment of structures over-represented (p < 0.001) in proteins downregulated in the absence of gp96 (Table 2), in comparison to
all proteins identified by ≥2 peptides.
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However, there must be further complexity as some α-integrins
containing a β-propeller, and some TLR proteins containing
the leucine-rich repeat are not dependent on gp96 for cell
surface expression.
CD180/Ly86 is a Novel gp96 Client
In addition to LDLR family members, CD180 (RP105, Ly78)
and Ly86 (MD1) both show decreased cell surface expression
in the absence of gp96 (Table 2). CD180 is related to TLRs,
contains leucine-rich repeats
32,33 and binds Ly86 (MD1).
34
Gp96 may be required for CD180/MD1 complex assembly, by
analogy to TLR4/MD2, as in the absence of gp96, TLR4 and
MD2 cannot associate.
3 Together CD180/Ly86 affect the
immune response to lipopolysaccharide (LPS) by interfereing
with an LPS-derived signal delivered through the CD14-MD2-
TLR4 complex.
35 Additional LRR-containing proteins down-
regulated in gp96-deficient cells include: Leucine-rich repeat-
containing protein 4C, Extracellular leucine-rich repeat and
fibronectin type-III domain-containing protein 1, Adhesion
molecule with Ig like domain 1, Leucine-rich repeats and
immunoglobulin-like domains protein 2 (Table 2).
Other Novel gp96 Clients or Interacting Partners
Ly86 may show decreased cell surface expression in gp96
deficient cells due to interaction with its LRR containing
partner, CD180. To investigate whether the surface localization
of some proteins was aberrant because their binding partners
are dependent on gp96 we searched all proteins identified by
≥2 peptides, down- or up-regulated >3 fold (Table 2) using
Cytoscape 2.8.2 to identify interacting partners (Figure S2,
Supporting Information). Fibronectin is a ligand for integrin
αV/β3,
36 which might explain its downregulation (19.6−39.8
fold) in gp96 deficient cells.
Correspondence of Mascot and Andromeda Ratios
Protein ratios generally corresponded well when data were
processed using either Mascot or Andromeda (Table S1,
Supporting Information) except when proteins were down-
regulated >3 fold, in which case the ratios generated using
either software corresponded less well (Table 2 and Table S2,
Supporting Information). Gp96 is critical for proper folding
and functional expression of a number of integrins and TLRs;
in gp96-deficient cells, these proteins are minimally expressed
at the cell surface as assessed by flow cytometry.
3,5 An optional
step in the MaxQuant workflow is the “requantify” strategy
where ratios are calculated for precursors not assembled into
SILAC pairs. This strategy is useful for quantifying low
abundance peptides with high ratios, where one of the
SILAC partners is at or below noise level,
24 as is likely here
for light labeled peptide derived from gp96 cell surface clients
(M36 cells). When we reprocessed data with requantify turned
off, there was much better correspondence between Mascot
and Andromeda ratios (Figure S3, Supporting Information)
albeit with a reduced number of quantified proteins.
■ DISCUSSION
We developed plasma membrane profiling to compare the
relative abundance of plasma membrane proteins in gp96-
deficient versus gp96-reconstituted murine pre-B cells. We
identified 706 PM proteins and found a requirement for gp96
in the cell surface expression of 29 of these proteins, including
integrins, TLRs, and four members of the extended LDL
receptor family (LDLR, LRP6, Sorl1 and LRP8). Our data
indicates that gp96 is required for assembly of this functionally
important class of proteins and suggests that it may be required
to chaperone folding of some beta-propeller domains and
leucine-rich repeats.
Our enrichment for PM proteins using PMP compares well
with other reports for plasma membrane protein preparations.
For example, sucrose density gradient with 2-phase partitioning
identified 428 proteins from rat liver with 67% showing plasma
membrane annotation.
37 Cationic silica microbeads identified a
total of 450 proteins from lung tissue with 81% plasma
membrane annotation.
38 We previously used cationic silica
microbeads to enrich PM proteins, to determine novel
substrates of the MARCH9 transmembrane E3 ligase
39 and
identified 157 PM proteins from an immortalised B-lymphocyte
cell line (16% of identified and annotated proteins). In our
experience, this technique is less reliable than the aminooxy-
biotin, giving lower yields and purity of plasma membrane
proteins. In comparison to the other techniques tried, including
crude membrane preparation, biotinylation of surface proteins
with N-hydroxysulfosuccinimydyl-S,S-biotin and cationic silica
microbeads, PMP gives us the best PM protein enrichment, the
greatest number of PM protein identifications and best
reproducibility between biological repeats.
20 Cell surface
capture (CSC) with biocytin hydrazide ligation of oxidized
cell surface glycoproteins identified 96−341 proteins, of which
95% were present at the cell surface, as defined by the presence
of at least one transmembrane or GPI anchor domain, a
consensus glycosylation motif and an asparagine to aspartic acid
deamidation site.
40 A major advantage of PMP over CSC is the
potential for increased protein sequence coverage and thus
improved quantitative accuracy. Whereas CSC identified 1−3
glycopeptides per protein identified, in this study and previous,
we identify 1−95 peptides per protein. Other potential
advantages of PMP using aminooxy-biotin over CSC with
biocytin hydrazide include the more stable product formation
with the oxime ligation of aminooxy-biotin to cell surface
aldehyde compared to the hydrazone ligation of biocytin
hydrazide.
41 The use of aniline as a catalyst enables use of
aminooxy-biotin at relatively low concentration (100 μM).
21
Following fractionation of the tryptic peptide sample, the
percentage of proteins annotated PM/CS/XC fell from 70 to
35%. The increased identification of non-PM contaminants
seen following high resolution fractionation suggests that
contaminants form a minor part of the total protein content
and highlights the efficiency of PM protein enrichment. Some
of these contaminants might include proteins endogenously
biotinylated at low level such as histones.
42 The decreased
percentage of proteins annotated PM/CS/XC in the
fractionated sample also suggests that a proportion of the 143
proteins annotated “short GO” may not be of PM origin.
Curation of the murine GO database is however likely to be
incompletefor example, protein S100-A14 (Table S2,
Supporting Information) was not annotated with GOCC
terms by Perseus, but resides at the plasma membrane.
43
An essential role for gp96 in the cell surface expression of
four of the ten members of the extended LDLR family adds
these functionally and clinically important proteins to the
integrins and TLRs in their requirement for gp96 for cell
surface expression. Cellular cholesterol uptake is likely to be
significantly diminished when cell surface expression of LDLR
and other family members is reduced, and may explain the
observed increase in proteins implicated in cholesterol
metabolism in gp96-deficient cells (Table S1, Supporting
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type I (upregulated 1.9 fold) which mediates the bidirectional
transfer of cholesterol between cells and HDL cholesterol,
44
hydroxymethylglutaryl-CoA synthase (Hmgcs1, upregulated 1.8
fold) which condenses acetyl-CoA with acetoacetyl-CoA to
form HMG-CoA, the substrate for HMG-CoA reductase,
45
acetoacetyl-CoA synthetase and fatty acid synthase. Together
these proteins may compensate for the reduction in cellular
cholesterol uptake through the induction of alternative uptake
or synthesis pathways. In addition, the mitochondrial/
peroxisomal protein delta(3,5)-delta(2,4)-dienoyl-CoA isomer-
ase (Ech1) was upregulated 4.1 fold in gp96 deficient cells
(Table 2)Ech1 acts in the alternative pathway for the beta-
oxidation of unsaturated fatty acids, a source of acetyl-CoA.
46
Increased Ech1 expression might also provide acetyl-CoA as a
substrate for Hmgcs1 and cholesterol synthesis, although other
metabolic pathways could also generate this important
intermediate.
Since gp96 appears likely to play a key role in chaperoning
the assembly of members of the extended LDLR, integrin and
TLR protein families, are there shared structural features which
shed light on the protein domains recognized by this chaperone
and explain its selectivity? A key candidate here is the beta-
propeller domain, which is formed from twisted β-sheet
structural repeats arranged toroidally around a central axis.
The extracellular domain of α-subunit integrins contains a
seven-bladed beta-propeller which complexes with the I/A
domain to form the ligand-binding head of the integrin.
47 All
members of the extended LDLR family share the same six-
bladed beta-propeller domain, formed by six contiguous YWTD
repeats. The core members of this family share further
structural features, with ligand-binding cysteine-rich repeats
followed by the beta-propeller, flanked by EGF-like cysteine-
rich repeats.
48 While these domains can be found individually in
other proteins, it is only in the LDLR family that they coexist in
the same protein.
49 Clearly, not all propeller domain-containing
proteins require gp96 for correct folding, but the unique
interface between the propeller and adjacent modules may
require gp96-assisted assembly. LDLR family members also
have a specific requirement for the molecular ER chaperone
boca (Drosophila melanogaster), and its mammlian orthologue
Mesd, for folding and trafficking to the cell surface.
50−52 In the
absence of this chaperone they are retained in the ER, where
gp96 is also most abundant. Boca/mesd is specifically required
for maturation of the LDLR family beta-propeller/EGF
modules,
53−55 and it will therefore be interesting to determine
whether Mesd interacts with gp96, and the relative roles of
these different chaperones in LDLR assembly. It will also be
necessary to confirm biochemically that the changes we observe
in surface expression of LDLR family members are due to the
absence of specific gp96 chaperone activity, as opposed to
changes in transcription or translation of individual client genes.
As the known functions of gp96 include chaperoning the
folding of proteins, targeting of misfolded proteins to ERAD
and storing calcium,
1 transcriptional effect would seem unlikely.
The known gp96 clients, integrins and TLRs, fail to reach the
cell surface in the absence of gp96 due to misfolding
1−8it is
therefore likely that LDLR family members are similarly
affected in the absence of gp96.
The TLRs play a critical role in innate immunity and are type
I transmembrane proteins with common structural features,
including an N-terminal ectodomain containing multiple
leucine-rich repeats for ligand binding, a short helix embedded
in the membrane and a C-terminal cytosolic tail containing the
Toll-interleukin-1 receptor (TIR) domain for recruiting
signaling adaptors. Though not containing any beta-propeller
domains, the widespread, structural leucine-rich repeat of 20−
30 amino acids has a characteristic repetitive sequence pattern,
built from tandem repeats to form curved solenoid structures,
particularly well suited for protein−protein interactions.
56 A
possible role for gp96 may therefore be chaperoning the
assembly of proteins with repeating units, such as repeated
leucine-rich repeats, or repeated subunits of a beta-propeller.
Gp96-deficient (M36 and E4.126) cells are resistant to
infection by vesicular stomatitis virus (VSV) and viruses
pseudotyped with VSV-G
13 suggesting that one or more of
the extended LDLR family, or indeed other gp96-dependent
proteins identified in this analysis may be the receptor for VSV-
G.
In summary, Gp96 is required for cell surface expression of at
least four members of the extended LDL receptor family, as
well CD180/Ly86 and most integrins and TLRs. Among the
proteins whose cell surface expression was gp96 dependent, we
found a significant enrichment for beta-propeller and leucine
rich repeats, suggesting an important role of gp96 in the folding
of these modules.
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